Show simple item record

dc.contributor.authorInfante-Garcia, Carmen
dc.contributor.authorRamos Rodríguez, Juan José
dc.contributor.authorMarín Zambrana, Yolanda
dc.contributor.authorFernández Ponce, María Teresa 
dc.contributor.authorCasas Cardoso, Lourdes 
dc.contributor.authorMantell Serrano, Casimiro 
dc.contributor.authorGarcía Alloza, Mónica 
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.contributor.otherIngeniería Química y Tecnología de Alimentoses_ES
dc.date.accessioned2024-11-27T07:14:08Z
dc.date.available2024-11-27T07:14:08Z
dc.date.issued2017
dc.identifier.issn1750-3639
dc.identifier.issn1015-6305
dc.identifier.urihttp://hdl.handle.net/10498/33933
dc.description.abstractEpidemiological studies reveal that metabolic disorders, and specifically type 2 diabetes (T2D), are relevant risk factors to develop Alzheimer's disease (AD) and vascular dementia (VaD), the most common causes of dementia. AD patients are in a tremendous need of new therapeutic options because of the limited success of available treatments. Natural polyphenols, and concretely Mangifera indica Linn extract (MGF), have been reported to have antiinflammatory, antioxidant and antidiabetic activities. The role of MGF in central complications associated with T2D, after long-term treatment of db/db mice with MGF was analyzed. Metabolic parameters (body weight, glucose and insulin levels) as well as central complications including brain atrophy, inflammatory processes, spontaneous bleeding, tau phosphorylation and cognitive function in db/db mice treated with MGF for 22 weeks were assessed. MGF limits body weight gain in obese db/db mice. Insulin and C-peptide levels, indicative of pancreatic function, were longer maintained in MGF-treated animals. MGF reduced central inflammation by lowering microglia burden, both in the cortex and the hippocampus. Likewise, central spontaneous bleeding was significantly reduced in db/db mice. Cortical and hippocampal atrophy was reduced in db/db mice and tau hyperphosphorylation was lower after MGF treatment, resulting in partial recovery of learning and memory disabilities. Altogether, the data suggested that MGF treatment may provide a useful tool to target different aspects of AD and VaD pathology, and could lead to more effective clinical therapies for the prevention of metabolic related central complications associated with AD and VaD.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherBlackwell Publishing Ltdes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceBrain Pathology - 2017, Vol. 27 n. 4 pp. 499-507es_ES
dc.subjectAlzheimer’s diseasees_ES
dc.subjectdiabetes, hemorrhagees_ES
dc.subjectinflammationes_ES
dc.subjectmango leaf extractes_ES
dc.subjectvascular dementiaes_ES
dc.titleMango leaf extract improves central pathology and cognitive impairment in a type 2 diabetes mouse modeles_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1111/BPA.12433
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional